Impacts of Midterm Elections on Healthcare Reimbursement Models

As the 2026 U.S. midterm elections loom, potential shifts in healthcare reimbursement and funding models could significantly impact the financial dynamics of hospitals and health systems across the nation.

Analysts from RSM highlight the possibility of strained hospital revenue streams due to alterations in Medicaid funding, the expiration of enhanced Affordable Care Act (ACA) premium tax credits, and the rise of site-neutral payments. The sector is further challenged by increasing coverage volatility and a surge in uninsured patients, which intensifies administrative burdens. This evolving landscape places particular stress on rural and safety-net providers that heavily depend on government payers.

Impact on Healthcare Reimbursement

Healthcare organizations must strategically navigate the unstable reimbursement terrain to sustain access to care and financial viability. Middle market hospitals, in particular, may face hurdles in areas such as staffing and capital investments, alongside financing long-term projects. The unpredictable reimbursement environment necessitates careful planning and adaptation.

The current political climate could influence these dynamics, especially with continued Republican control perhaps prompting stronger Medicaid eligibility criteria and sustained provider-tax reductions. Alternatively, a divided government might focus on regulatory scrutiny and essential legislative reforms, offering potential pathways for provider-tax relief and payment recalibrations. Additionally, the Centers for Medicare & Medicaid Services (CMS) is likely to persist in promoting site-neutral payment reforms.

State-Level Influences and Policy Considerations

State policies will also significantly influence Medicaid financing strategies and overall federal funding. Healthcare leaders will need to closely monitor whether state policymakers will address these challenges proactively or allow them to escalate, particularly given the anticipated Medicaid funding reductions post-2027.

Affordability and coverage accessibility continue to be pivotal policy concerns. The cessation of heightened ACA premium tax credits escalates costs for consumers and may increase coverage attrition, fueling debates on the need for federal premium support. Congress is actively addressing healthcare costs, with ongoing discussions about drug pricing, pharmacy benefit manager reform, and price transparency reflecting a bipartisan commitment to fostering accountability and affordability.

Looking Forward: Federal and State Initiatives

The appointment of Ge Bai as Assistant Secretary for the U.S. Department of Health and Human Services underscores the administration's resolve to prioritize affordability. Bai's expertise in hospital pricing and accountability provides a strong regulatory basis for advancing affordability initiatives through HHS and CMS. Hospitals might face more rigorous evaluations of pricing strategies and community benefits, independent of new legislative mandates.

States are likely to advance affordability through coverage programs, transparency demands, and stringent provider oversight. This shift marks a transition from considering affordability as a mere political topic to integrating it into policy frameworks that will shape reimbursement, regulation, and compliance for years to come.

Projected data from CMS estimates that U.S. healthcare spending will grow from $5.3 trillion in 2024 to nearly $9 trillion by 2034, with healthcare's share of the GDP rising to 20.6%. As Medicare growth significantly contributes to this increase, healthcare affordability and spending will remain crucial concerns for Congress and policymakers.

As the political landscape unfolds, healthcare organizations are advised to focus on building operational resilience to adapt swiftly to the changing reimbursement, coverage, and regulatory frameworks. This proactive approach will ensure they remain agile and prepared for upcoming challenges.